SCHEMBL2937262

SCHEMBL2937262

Cc1ccc(S(=O)(=O)N=[S@@](C)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.77
▸ KMT2A Q03164 5/20 0.66
▸ MEN1 O00255 4/20 0.66
▸ PIR O00625 1/20 0.53
▸ ACHE P22303 2/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ BCHE P06276 1/20 0.46
▸ F2 P00734 2/20 0.45
▸ PRSS1 P07477 2/20 0.45
▸ PRSS2 P07478 2/20 0.45
▸ PRSS3 P35030 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ RAB9A P51151 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ CXCR5 P32302 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1775480 1.00 CYP2C19 (0.77) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL1775481 1.00 CYP2C19 (0.77) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL1774413 0.94 CYP2C19 (0.65) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL1774411 0.94 CYP2C19 (0.65) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL2935232 0.94 CYP2C19 (0.65) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL17015173 0.87 CYP2C19 (1.00) CYP2C19KMT2AMEN1PIRSMN1; SMN2
SCHEMBL16317067 0.87 CYP2C19 (1.00) CYP2C19KMT2AMEN1PIRSMN1; SMN2
SCHEMBL14355817 0.87 CYP2C19 (0.56) CYP2C19KMT2AMEN1PIRACHE
SCHEMBL2938712 0.85 CYP2C19 (0.54) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL1774767 0.85 CYP2C19 (0.54) CYP2C19KMT2AMEN1PIRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029552-B1 SULFIMIDES AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2010-09-22 — — EP disclosed
EP-2029552-A1 SULFIMIDES AS PROTEIN KINASE INHIBITORS Bayer Schering Pharma AG (DE) 2009-03-04 — — EP disclosed
WO-2007140957-A1 SULFIMIDES AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-12-13 — — WO disclosed
Send feedback